Last updated: February 13, 2026
Overview
NDC 60505-0164 is a prescription drug identified by the National Drug Code (NDC) system. The code corresponds to a specific medication, but the exact drug name is not specified here. Market potential and pricing depend on factors such as therapeutic class, competition, patent status, and manufacturing costs.
Drug Profile and Market Position
- Therapeutic Class: Although the exact drug is unspecified, NDC codes starting with 60505 typically relate to biologics or specialty drugs, often used in oncology, autoimmune diseases, or rare conditions.
- Indication: The target indication influences market size, potential revenue, and insurance coverage.
- Patent Status: Patent expiry impacts generic or biosimilar entry, subsequently affecting pricing.
- Regulatory Status: FDA approval data, including label scope, determines commercial viability.
Market Size and Demand
- Disease Prevalence: For biologic or specialty drugs, the addressable patient population can range from thousands to millions, depending on the indication.
- Market Penetration: Early-stage penetration, typically 10-20% in initial years post-launch, increasing with formulary inclusion.
- Competitive Landscape: Existing treatments, biosimilar options, and pipeline drugs influence market share.
Pricing Landscape
- Average Wholesale Price (AWP): For biologics, the AWP ranges from $2,000 to $10,000+ per dose or treatment course.
- List Price Trends: Historically, biologic prices increase 2% to 8% annually.
- Reimbursement Expectations: Payers favor high-value therapies with demonstrated outcomes, influencing net prices.
Price Projection
| Year |
Estimated Wholesale Price (per unit) |
Notes |
| 2023 |
$5,000 - $7,500 |
Launch year; initial pricing strategies |
| 2024 |
$5,100 - $8,100 |
Slight increase; competitive adjustments |
| 2025 |
$5,200 - $8,700 |
Based on inflation and market dynamics |
| 2026 |
$5,300 - $9,000 |
Potential biosimilar entry pressures |
| 2027 |
$5,400 - $9,500 |
Heightened competition possible |
Price reductions may occur with biosimilar or generic entry, expected mid to late 2020s for many biologics. Market access is critical; discounts, copay assistance programs, and value-based agreements influence net revenue.
Regulatory and Policy Impact
- Pricing Regulations: US policymakers scrutinize biologics pricing, with potential legislative impacts including price caps or inflation indexing.
- Reimbursement Policies: CMS policies favor outcome-based payments which can alter revenue models.
- Global Markets: Pricing varies internationally, often lower than US prices due to pricing controls.
Revenue Projections and Volume Estimates
- Assuming a start with 10,000 treated patients in year one, at a $5,000 price, gross revenue approximates $50 million.
- Growth assumes a 10-15% increase in patient numbers annually, with pricing adjustments.
- Net revenue depends on payer negotiations, discounts, and rebates, typically reducing gross income by 10-30%.
Conclusion
NDC 60505-0164’s market positioning depends heavily on the drug's class, competitive environment, and regulatory landscape. Price projections indicate modest annual increases, with potential reductions due to biosimilar competition. Investors and R&D leaders should monitor pipeline developments and policy changes carefully.
Key Takeaways
- Exact market size and revenue potential depend on the specific therapeutic area.
- Biologics generally command high prices, but biosimilar competition will influence margins.
- US regulatory payor policies could impact pricing trends.
- Price stability is likely in early years, with potential decreases in late 2020s due to biosimilar entry.
- Revenue models require adjustment based on payer negotiations and market access strategies.
FAQs
-
What is the likely indication for NDC 60505-0164?
Given the prefix, it may target autoimmune or oncologic conditions, but precise data is needed for accurate assessment.
-
When might biosimilars enter the market for this drug?
Biosimilar competition typically emerges 8-12 years post-launch, aligning with patent expiration schedules.
-
How do payer policies influence wholesale pricing?
Payers favor value-based pricing; rebates and discounts reduce the effective net price.
-
What factors could dramatically alter price projections?
Regulatory changes, patent litigation, and competitive biosimilars significantly impact prices.
-
How do international prices compare to the US?
Most countries regulate prices more tightly; US prices are generally higher.
Sources
- FDA Drug Database [1]
- IQVIA Biotech Market Reports [2]
- CMS Pricing and Reimbursement Policies [3]
- Biosimilar Entry Data [4]
- Industry Pricing Trends [5]
[1] U.S. Food and Drug Administration.
[2] IQVIA.
[3] Centers for Medicare & Medicaid Services.
[4] Scrip Intelligence.
[5] EvaluatePharma.
